HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Balazs Koszegi Selected Research

Therapeutics

8/2021Cytostatic Effect of a Novel Mitochondria-Targeted Pyrroline Nitroxide in Human Breast Cancer Lines.
2/2021Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Balazs Koszegi Research Topics

Disease

2Triple Negative Breast Neoplasms
08/2021 - 02/2021
2Breast Neoplasms (Breast Cancer)
08/2021 - 02/2021
1Coinfection
12/2013

Drug/Important Bio-Agent (IBA)

1pyrrolineIBA
08/2021
1nitroxylIBA
08/2021
1mito-carboxy proxylIBA
08/2021
1Cytostatic AgentsIBA
08/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2021
1Hormones (Hormone)IBA
02/2021
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
02/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
02/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
02/2021
1olaparibIBA
02/2021
1Platinum Compounds (Compounds, Platinum)IBA
02/2021
1MycotoxinsIBA
12/2013

Therapy/Procedure

2Therapeutics
08/2021 - 02/2021